Inozyme Pharma Inc (INZY)

Precedente Chiudi:

$4.67

Aprire:

$4.67

Volume 24 ore:

215.13K

Capitalizzazione di mercato:

$292.58M

Reddito:

-

Utile/perdita netta:

$-71.17M

Rapporto P/E:

-3.0516

EPS:

-1.55

Flusso di cassa netto:

$-70.97M

1 W Prestazione:

+1.72%

1M Prestazione:

-2.47%

6M Prestazione:

+46.89%

1 anno Prestazione:

-28.87%

Intervallo 1D:

$4.59

$4.74

Portata 52W:

$2.689

$7.795

Inozyme Pharma Inc Stock (INZY) Company Profile

Nome

Inozyme Pharma Inc

Settore

Healthcare (1211)

Industria

Biotechnology (697)

Telefono

-

Indirizzo

700 Technology Square, Floor 2, Cambridge

Dipendente

24

Cinguettio

Prossima data di guadagno

2024-05-15

Ultimi documenti SEC

INZY's Discussions on Twitter

Inozyme Pharma Inc Stock (INZY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-03-23	Aggiornamento	Jefferies	Hold → Buy
2022-05-26	Iniziato	Jefferies	Hold
2022-02-07	Iniziato	H.C. Wainwright	Buy
2021-11-29	Iniziato	Needham	Buy
2020-08-18	Iniziato	BofA Securities	Buy
2020-08-18	Iniziato	Cowen	Outperform
2020-08-18	Iniziato	Piper Sandler	Overweight
2020-08-18	Iniziato	Wedbush	Outperform

Mostra tutto

Inozyme Pharma Inc Borsa (INZY) Ultime notizie

Inozyme Pharma, Inc. (NASDAQ:INZY) Short Interest Update - MarketBeat

MarketBeat

Inozyme Pharma, Inc. (NASDAQ:INZY) Sees Significant Increase in Short Interest - Defense World

Defense World

Inozyme Pharma (NASDAQ:INZY) Receives “Buy” Rating from Needham & Company LLC - Defense World

Defense World

Q2 2024 Earnings Estimate for Inozyme Pharma, Inc. Issued By HC Wainwright (NASDAQ:INZY) - MarketBeat

MarketBeat

Wedbush Weighs in on Inozyme Pharma, Inc.'s Q1 2025 Earnings (NASDAQ:INZY) - MarketBeat

MarketBeat

Needham & Company LLC Reiterates Buy Rating for Inozyme Pharma (NASDAQ:INZY) - MarketBeat

MarketBeat

Inozyme Pharma Inc Azioni (INZY) Dati Finanziari

Inozyme Pharma Inc (INZY) Reddito netto 2024

Inozyme Pharma Inc (INZY) Flusso di cassa 2024

Inozyme Pharma Inc (INZY) Utile per azione 2024